Real-world study reports promising first-line orelabrutinib outcomes in CLL/SLL
A retrospective single-center study of 75 treatment-naive CLL/SLL patients reports an 86.7% response rate with frontline orelabrutinib monotherapy and no ...
A retrospective single-center study of 75 treatment-naive CLL/SLL patients reports an 86.7% response rate with frontline orelabrutinib monotherapy and no ...
A spatial transcriptomics study links depletion of non-tumoral B cells to relapse risk in classical Hodgkin lymphoma and introduces an ...
A 55-CpG DNA methylation signature developed from bone marrow samples and validated in an independent cohort appears to predict AML ...
A retrospective Kenyan study of 773 people found MCV had near-chance accuracy for detecting haemoglobinopathies, with sickle cell disease phenotypes ...
A scoping review of 75 rodent studies finds recurring hematologic suppression and kidney injury in therapeutic radiopharmaceutical safety testing, but ...
A case report describes the first known link between anti-Homer3 antibody-positive autoimmune cerebellar ataxia and diffuse large B-cell lymphoma, while ...
A 28-day trial in Pakistan found that dietary moringa leaf powder and spirulina partially restored blood values and reduced tissue ...
A case report describes a PNH patient whose anemia and transfusion needs improved after danicopan was added to ravulizumab therapy.
A case report describes a woman with lupus and autoimmune hemolytic anemia whose parvovirus B19-driven pure red cell aplasia responded ...
A case report in Oncoscience details a patient with metastatic lung cancer who developed severe Coombs-negative hemolytic anemia after pembrolizumab ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine